Risk of Dis-lipids Syndrome in Modern Society

Authors

  • Aurelian Udristioiu Department of Biochemistry, Clinical Laboratory, Emergency County Hospital, Targu Jiu & Titu Maiorescu Universitatea, Taragu Jiu, Romania
  • Manole Cojocaru Department of Physiology, Faculty of Medicine, Titu Maiorescu University, Bucharest, Romania

DOI:

https://doi.org/10.53555/hsn.v2i4.276

Keywords:

low density lipoprotein, very low density lipoproteins, intermediate density lipoproteins, cholesterol, triglycerides chylo-microns.

Abstract

Aim of this work was to emphasis the preclinical evaluation of dis-lipids syndromes types at the patients which were presented to a routine control for checking health status, in the hospital ambulatory.Material and Method: Were analyzed 60 patients, registered in Clinical Laboratory, assessing by running on the Hitachi 912 Analyzer, the principal biochemical parameters of lipid metabolism: Cholesterol, Triglycerides and fractions of Cholesterol, HDL and LDL. From the total of 60 patients 35 were females and 25 males. Results The persons with an alarm signal of atherosclerotic process were in 28 % and persons with low HDL was in 17%. The cases with atherosclerotic index, report-LDL/HDL>3.5 for men and 2.5 for women were in 14 % , the cases with predictive value with coronary risk, reportCO/HDL>5 were presented in 5 % and the cases with dis-lipid syndrome type 2- 4, with high Cholesterol and Triglycerides, were presented in 30% percent. Conclusions Lipids controls, and its fractions, are necessary to be prevented atherosclerotic process in the incipient status of ill.

Downloads

Download data is not yet available.

References

Kelly GS. Insulin resistance: lifestyle and nutritional interventions[Abstract]. AlternMed Rev 2000;5(2):109-32.

Povel CM, Boer JMA, Imholz S, Dolle ETM, Feskens EJM. Genetic variants in lipid metabolism are independently associated with multiple features of the metabolic syndrome.Lipids Health Dis 2011;10:118.

Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA2002;288(21):2709-16.

Prabhakaran D, Anand SS. The metabolic syndrome: an emerging risk state forcardiovascular disease. Vascular Medicine 2004;9: 55-68.

GasevicD,FrohlichJ,ManciniGBJ, LearSA.Clinical usefulness of lipid ratios to identify men and women with metabolic syndrome: a cross-sectional study. LipidsinHealthandDisease2014;13:159.

Kopprasch S, Pietzsch J, Kuhlisch E, Fuecker K, Temelkova-Kurktschiev T, Hanefeld M, et al. In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance [Abstract].Diabetes2002; 51(10):3102-6.

Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron, J, et al. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men.JAMAInternalMedicine2001;1(22):12685-9.

CummingsBP, BettaiebA,GrahamJL, StanhopeKL, DillR, Morton GJ, et al. Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type2 diabetic UCD-T2DM rats. Proc Natl Acad Sci2011;108(35):14670–5.

J Cholesterol and Health: Cholesterol is the Precursor to allSteroid Hormones.Masterjohn C. (9)2; 2005. Available from: www.cholesterol-and-health.com/(Accessed November 2015).

ChemWiki:Biological Chemistry, Lipids, Glycerides, Triglycerides: The Dynamic Chemistry Hypertext. Available from: chemwiki.ucdavis.edu (Accessed November 2015).

National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).http://circ.ahajournals.org/(Accessed November 2015).

Eckel RH, Jakicic JM, Ard DJ, Jesus JM,; Mille IM,Hubbard SV, et al. 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. J Am Coll Cardiol2014;63(25_PA).

Rifai N, Warnick GR. Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 4th Ed. St. Louis (MO): Elsevier Saunders; 2006. p. 903-81.

Uera-Moya M, Drazul-Schrader D, Astzlos BF, Vaugham AM, Lund-KatzS. The ability to promote efflux bia ABCA1 determines the capacity of serum specimentswith similar high sensitivity lipoprotein cholesterol to remove cholesterol from macrophages. Arterioscler Thromb Vasc Biol 2010; 30;796-801.

Rudeling JM, Reihn RO, Einsarson K, Angelin ES. Low density lipoprotein receptor-binding activity in human tissues: Quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo (cholesterol/cholestyramine/low densitylipoproteins/liver/metabolic regulation). ProcNati Acad Sci 2013; (87): 3469-73.

Gomez D, Owens GK. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res2012;95:156–64.

Rosenbaum R, Goldsmith R, Bloomfield D, Magnano A, WeimerL, HeymsfieldSet al. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest 2005; 115(12): 3579–86.

Downloads

Published

2016-04-30

How to Cite

Udristioiu, A., & Cojocaru, M. (2016). Risk of Dis-lipids Syndrome in Modern Society. International Journal For Research In Health Sciences And Nursing, 2(4), 43–51. https://doi.org/10.53555/hsn.v2i4.276